Immunological profiling as a means to invigorate personalized cancer treatment

Joost Hegmans; Joachim Aerts

doi:10.4161/onci.25236

Immunological profiling as a means to invigorate personalized cancer treatment

Joost Hegmans, Joachim Aerts

Pulmonary Medicine

Research output: Contribution to journal › Article › Academic › peer-review

5 Citations (Scopus)

Abstract

Immunotherapy has taken of but has not yet reached its cruising altitude and is certainly far from its final destination. Identifying the unique immunological profile of individual cancer patients will provide critical clues for the design of optimal strategies that rectify tumor-induced immune imbalances.

Original language	Undefined/Unknown
Journal	OncoImmunology
Volume	2
Issue number	8
DOIs	https://doi.org/10.4161/onci.25236
Publication status	Published - 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.4161/onci.25236

Cite this

@article{360b81afc4734e2c98a21a794202f135,

title = "Immunological profiling as a means to invigorate personalized cancer treatment",

abstract = "Immunotherapy has taken of but has not yet reached its cruising altitude and is certainly far from its final destination. Identifying the unique immunological profile of individual cancer patients will provide critical clues for the design of optimal strategies that rectify tumor-induced immune imbalances.",

author = "Joost Hegmans and Joachim Aerts",

year = "2013",

doi = "10.4161/onci.25236",

language = "Undefined/Unknown",

volume = "2",

journal = "OncoImmunology",

issn = "2162-4011",

publisher = "Landes Bioscience",

number = "8",

}

TY - JOUR

T1 - Immunological profiling as a means to invigorate personalized cancer treatment

AU - Hegmans, Joost

AU - Aerts, Joachim

PY - 2013

Y1 - 2013

N2 - Immunotherapy has taken of but has not yet reached its cruising altitude and is certainly far from its final destination. Identifying the unique immunological profile of individual cancer patients will provide critical clues for the design of optimal strategies that rectify tumor-induced immune imbalances.

AB - Immunotherapy has taken of but has not yet reached its cruising altitude and is certainly far from its final destination. Identifying the unique immunological profile of individual cancer patients will provide critical clues for the design of optimal strategies that rectify tumor-induced immune imbalances.

U2 - 10.4161/onci.25236

DO - 10.4161/onci.25236

M3 - Article

SN - 2162-4011

VL - 2

JO - OncoImmunology

JF - OncoImmunology

IS - 8

ER -